Etid klinik pou Avèg nan Kalifòni
3 etid pou Avèg ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
- Adverum Clinical Site 109, Bakersfield
- Adverum Clinical Site 100, Beverly Hills
- Adverum Clinical Site 201, Campbell
- ak 10 plis
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07482176Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 109, Bakersfield
- Adverum site 169, Fullerton
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07630649Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06891443Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.